Dr. Asif Pathan joined AROG Pharmaceuticals in April 2018 and is primarily responsible for overseeing the clinical pharmacology studies of AROG’s novel anticancer molecule. He brings extensive expertise in preclinical and clinical drug discovery research stemming from CRO, pharmaceutical industry and academic research. Before joining AROG Pharmaceuticals, Dr. Pathan worked as Clinical Research Associate with Medpace, where he monitored the clinical development of new drug molecules in several therapeutic areas including oncology. During his tenure as a Postdoctoral Scientist at the Institute of Molecular Cardiology, University of Louisville, Kentucky, he focused on developing regenerative cellular therapy for heart diseases. Dr. Pathan also worked as Research Scientist at the Nicholas Piramal India Limited, where he and his colleagues developed novel nitric oxide (NO)-releasing NSAID compounds and studied their pharmacokinetic and pharmacodynamic properties.

Dr. Pathan received his PhD in Pharmacology from the University of Arkansas for Medical Sciences, Little Rock, USA; MS in pharmacology from the National Institute of Pharmaceutical Education in Research, Mohali (India); and Bachelor of Pharmacy from Government College of Pharmacy, Karad (India). He is consulting editor for journal, Drug Design, Development and Therapy and has published his own research in several high impact journals. He also co-authored 2 book chapters and participated in nearly a dozen conference presentations.